Le Lézard
Classified in: Health
Subject: SVY

FDAnews Announces -- The GMP Letter Newsletter Subscription


FALLS CHURCH, Va., March 27, 2020 /PRNewswire-PRWeb/ -- The GMP Letter
An FDAnews Newsletter
https://www.fdanews.com/subscribe-now/the-gmp-letter

Inspections... quality regulations... guidances... recalls... CAPA... MDR reporting... cybersecurity... UDI...

What is it like to have access to the inner workings of the FDA or a trusted friend there to share insights into the interpretation and enforcement of cGMPs and quality systems regulation (QSR)?

The GMP Letter is the go-to resource. This newsletter has the insights and latest news one can rely on to ensure the processes, procedures and controls are compliant.

Each month, The GMP Letter's executive briefings bring subscribers the latest on:

?FDA's approach to facility inspections such as the agency's increasing focus on data security
?Changes to the EU's inspections for MDR compliance
?Joint recognition of GMP inspections in the U.S., EU and other jurisdictions
?Quality regulations and guidances for instance on cybersecurity and data integrity

For the past 30 years, devicemakers who have relied on The GMP Letter have had much-needed information and analysis, enabling them to act swiftly to adjust manufacturing processes.

Bonus! Subscribers also receive critical documents including 483s, warning letters, closeout letters, FDA policy notices and more.

Start a one-year subscription (12 issues) to The GMP Letter for only $1,085. Take advantage of our 100% Money-Back Guarantee. We're confident the value GMP provides will pay for itself many times over.

Newsletter Details:
Drug GMP Report
An FDAnews Newsletter
https://www.fdanews.com/subscribe-now/drug-gmp-report

Subscription:
$1,085

Easy Ways to Register:
Online: https://www.fdanews.com/subscribe-now/drug-gmp-report
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

 

SOURCE FDAnews


These press releases may also interest you

at 05:25
PureTech Health plc ("PureTech" or the "Company") today announces its results for the year ended December 31, 2023, as well as its cash balance as of the first quarter ended March 31, 2024. The following information represents select highlights from...

at 05:11
Hyundai Bioscience announced on April 25th that its clinical development plan of oral "Niclosamide Metabolic Anticancer Drug" targeting cancer patients with intractable cancer caused by p53 gene mutations. Mutations in the p53 gene occur in almost...

at 04:31
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR...

at 04:30
The Balance RehabClinic, renowned for its luxury mental health and addiction services, proudly announces its expansion into The Balance Healthcare Group: a collection of premium mental health solutions tailored for affluent individuals. These new...

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...



News published on and distributed by: